Compounds > vindesine
Page last updated: 2024-08-23

vindesine and Diffuse Mixed Small and Large Cell Lymphoma

vindesine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 61 studies

Research

Studies (61)

TimeframeStudies, this research(%)All Research%
pre-19909 (14.75)18.7374
1990's30 (49.18)18.2507
2000's16 (26.23)29.6817
2010's6 (9.84)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J; Ping, P; Sun, Y; Xu, Y; Yao, C; Yin, H1
Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A1
Chen, L; Du, JW; Li, MH; Li, YF; Mi, RH; Wei, XD; Yin, QS1
Ben Salah, H; Boudawara, T; Daoud, J; Elloumi, M; Fourati, N; Frikha, M1
Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P1
Aarden, L; Baars, JW; Beijnen, JH; Huitema, AD; Tran, L1
Contentin, N; Dominique, S; Dubruille, V; Le Guillou, F; Nouvet, G; Tilly, H1
Attal, M; Blanc, M; Bosly, A; Coiffier, B; Fillet, G; Gisselbrecht, C; Guettier, C; Herbrecht, R; Lepage, E; Molina, TJ; Reyes, F; Tilly, H1
André, M; Bosly, A; Brice, P; Coiffier, B; Gaulard, P; Gisselbrecht, C; Haioun, C; Henry-Amar, M; Leleu, X; Morel, P; Mounier, N; Reyes, F; Sonet, A; Tilly, H1
Berthou, C; Casassus, P; Colombat, P; Deconinck, E; Delwail, V; Desablens, B; Foussard, C; Ghandour, C; Gressin, R; Lamy, T; Mahé, B; Maisonneuve, H; Pignon, B; Rachieru, P; Rousselet, MC1
Bosly, A; Brice, P; Coiffier, B; Ferme, C; Ganem, G; Laurent, G; Lederlin, P; Lepage, E; Molina, TJ; Morel, P; Reyes, F; Tilly, H1
Armitage, JO1
Coiffier, B; Reyes, F1
Tanvetyanon, T1
Hinkelbein, W; Hoecht, S1
Adli, M; Kalender, ME; Sevinc, A1
Fukuda, H; Fukuhara, S; Hirose, Y; Hotta, T; Kawano, F; Kikuchi, M; Mizoroki, F; Nakata, M; Nasu, K; Ohno, Y; Sano, M; Sawada, K; Shimoyama, M; Taniwaki, M; Tobinai, K; Togawa, A; Toki, H; Uozumi, K1
Denning, B; Fontana, JA; Knost, JA; Raich, PC; Rogers, JS; Subramanian, VP; Walker, BK1
Carcassonne, Y; Gastaut, JA; Maraninchi, D; Tubiana, N1
Bastion, Y; Baumelou, E; Bouabdallah, K; Delannoy, A; Dupriez, B; Haioun, C; Herbrecht, R; Morel, P; Nouvel, C; Tilly, H1
Angus, B; Carey, P; Evans, RG; Jackson, GH; Lennard, AL; Lucraft, H; Proctor, SJ; Taylor, PR1
Bosly, A; Coiffier, B; D'Agay, MF; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Morel, P; Nouvel, C; Tilly, H1
Bosly, A; Coiffier, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Morel, P; Reyes, F; Sebban, C; Tilly, H1
Bajetta, E; Buzzoni, R; Colleoni, M; Nelli, P; Nolè, F1
Battista, C; Bevilacqua, N; Chiurazzi, B; Cocorocchio, E; Esposito, G; Iodice, G; Pacilio, G; Panza, N1
Birkmann, J; Eschenbach, I; Gropp, C; Holle, R; Köppler, H; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, UE; Zeller, W1
Hattori, M; Morii, K; Sampi, K; Takagi, T1
Briere, J; d'Agay, MF; Diebold, J; Fillet, G; Gaulard, P; Haioun, C; Hermine, O; Lavignac, C; Lepage, E; Marolleau, JP; Reyas, F; Salles, G1
Audhuy, B; Blanc, M; Brière, J; Coiffier, B; Diviné, M; Dupriez, B; Herbrecht, R; Lederlin, P; Lepage, E; Mineur, P; Pautier, P; Reyes, F; Tilly, H1
Kobayashi, K; Matano, S; Matsuda, T; Misaki, T; Nakamura, S; Sugimoto, T1
Abella, E; Al-Katib, A; Heilbrun, LK; Karanes, C; Kasten-Sportes, C; Lum, L; Momin, F; Ratanatharathorn, V; Uberti, JP; Varterasian, M1
Alberto, P; Anchisi, S; Dietrich, PY; Laurencet, FM; Mermillod, B; Zulian, GB1
Aguiló, J; García, F; Gómez, A; Grau, E; Ibáñez, JL; Mirabet, MD; Pastor, E; Perella, M1
Bastion, Y; Bosly, A; Coiffier, B; Dabouz-Harrouche, F; Deconinck, E; Dupriez, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Marit, G; Marolleau, JP; Reyes, F; Tilly, H; Yver, A1
Angus, B; Cameron, DA; Cook, MK; Dawes, PJ; Dawson, AA; Evans, RG; Galloway, MJ; Harris, AL; Heppleston, A; Horne, CH; Krajewski, AS; Lennard, AL; Leonard, RC; Lessells, AM; Lucraft, HH; MacGillivray, JB; Mackie, MJ; Parker, AC; Prescott, RJ; Proctor, SJ; Roberts, JT; Taylor, PR; Thompson, WD; White, JM1
Katai, H; Kinoshita, T; Maruyama, K; Matsuno, Y; Sano, T; Sasako, M; Takenaka, T1
Brice, P; Cazals, D; Deconinck, E; Doyen, C; Gisselbrecht, C; Hamelsand, J; Molina, T; Moulonguet, I; Mounier, N; Neidhart-Berard, AM; Remenieras, L; Verola, O1
Bienvenu, J; Charlot, C; Coiffier, B; Ribeiro, P; Rigal, D; Roy, P; Salles, G; Warzocha, K1
Baumelou, E; Caubarrere, I; Couderc, LJ; Epardeau, B; Frachon, I; Hermine, O; Stelianides, S; Stern, M1
Bibi Triki, T; Brice, P; Fermé, C; Fitoussi, O; Gisselbrecht, C; Hennequin, C; Makke, J; Scrobohaci, ML; Simon, D1
Hasegawa, Y; Itoh, T; Kojima, H; Komeno, T; Mori, N; Nagasawa, T; Ninomiya, H; Tamagawa, Y; Yatabe, Y1
Bouabdallah, R; Cole, BF; Gisselbrecht, C; Haioun, C; Lepage, E; Marit, G; Morel, P; Mounier, N; Ravoet, C; Reyes, F; Salles, G; Sebban, C1
Bosly, A; Brice, P; Brière, J; Coiffier, B; Gaulard, P; Gisselbrecht, C; Haioun, C; Lederlin, P; Lepage, E; Morel, P; Nouvel, C; Reyes, F; Salles, G; Sebban, C; Tilly, H1
Cazals-Hatem, D; Chevret, S; Clauvel, JP; Dubreuil, ML; Gerard, L; Levy, Y; Matheron, S; Oksenhendler, E1
Baumelou, E; Brousse, C; Morel, P1
Bordessoule, D; Bosly, A; Coiffier, B; Deconninck, E; Divine, M; Dupriez, B; Fillet, G; Gaulard, P; Gisselbrecht, C; Herbrecht, R; Lepage, E; Nouvel, C; Tilly, H1
Bastion, Y; Blanc, M; Bryon, PA; Coiffier, B; Dumontet, C; Felman, P; Ffrench, M; Peaud, PY1
Coiffier, B; Farcet, JP; Gabarre, J; Gastaldi, R; Gisselbrecht, C; Lepage, E; Oksenjendler, E; Raphael, M; Thyss, A; Tirelli, U1
Bergerat, JP; Damonte, JC; Dufour, P; Herbrecht, R; Liu, KL; Maloisel, F; Oberling, F; Ortiz, S1
Chisa, M; Hasegawa, S; Katoh, M; Koike, M; Kubomatsu, Y; Kunika, N; Nakamura, K; Sano, F; Takahashi, M; Wakayama, T1
Oguro, M; Sakai, C; Takagi, T1
Armitage, JO; Bosly, A; Coiffier, B; Gisselbrecht, C; Herbrecht, R; Tilly, H; Vose, JM1
Bruntsch, U; Eschenbach, I; Gropp, C; Köppler, H; Lötzke, E; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, EU; Zeller, W1
Hattori, M; Sampi, K; Takouda, K1
Bergerat, JP; Duclos, B; Dufour, P; Garcia, JJ; Herbrecht, R; Oberling, F1
Kano, Y; Masaoka, T; Mikuni, C; Sakamoto, S; Sampi, K; Takagi, T1
Callís, M; Domingo Albós, A; Fernández-Sevilla, A; Juliá, A; Petit, J; Puig, J; Vilá, J; Zuazu, J1
Allan, NC; Dawson, AA; Leonard, RC; Lucraft, HH; McGillivray, JB; Parker, AC; Prescott, RJ; Proctor, SJ1
Abel, U; Fritze, D; Heim, ME; Ho, AD; Mebes, W1
Barbet, J; Cano, JP; Gastaut, JA; Imbert, AM; Lejeune, C; Lena, N; Maraninchi, D; Sainty, D; Sebahoun, G; Tubiana, N1

Reviews

2 review(s) available for vindesine and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective.
    Oncology (Williston Park, N.Y.), 2005, Volume: 19, Issue:4 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; France; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Prednisone; Vindesine

2005
Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases.
    Respiratory medicine, 1999, Volume: 93, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Pulmonary Fibrosis; Retrospective Studies; Vindesine

1999

Trials

23 trial(s) available for vindesine and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
    American journal of hematology, 2014, Volume: 89, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine

2014
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.
    Blood, 2003, Dec-15, Volume: 102, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Survival Rate; Vincristine; Vindesine

2003
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:3

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Risk Factors; Vidarabine; Vindesine

2005
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
    The New England journal of medicine, 2005, Mar-24, Volume: 352, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine; Vindesine

2005
A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.
    International journal of hematology, 2006, Volume: 83, Issue:1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisolone; Procarbazine; Treatment Outcome; Vincristine; Vindesine

2006
Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
    British journal of cancer, 1994, Volume: 70, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Creatinine; Cyclophosphamide; Doxorubicin; Female; Humans; Kidney; Kidney Neoplasms; L-Lactate Dehydrogenase; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Proportional Hazards Models; Remission Induction; Survival Analysis; Survival Rate; Treatment Outcome; Vindesine

1994
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
    British journal of cancer, 1994, Volume: 70, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Bone Marrow Transplantation; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Prednisolone; Retrospective Studies; Risk Factors; Vincristine; Vindesine

1994
Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Confidence Intervals; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prospective Studies; Remission Induction; Risk Factors; Transplantation, Autologous; Vindesine

1994
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:8

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Vindesine

1993
Results of a salvage regimen in refractory or relapsed non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1994, Volume: 14, Issue:1-2

    Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Prognosis; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vindesine

1994
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vincristine; Vindesine

1994
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Blood, 1996, Jan-01, Volume: 87, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Life Tables; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Prednisone; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Risk; Vindesine

1996
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
    Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lenograstim; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Placebos; Recombinant Proteins; Survival Rate; Treatment Outcome; Vindesine

1997
CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Survival Rate; Vincristine; Vindesine

1997
A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
    British journal of cancer, 1997, Volume: 76, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prognosis; Prospective Studies; Stomach Neoplasms; Vincristine; Vindesine

1997
Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
    Leukemia, 1998, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Skin Neoplasms; Treatment Outcome; Vincristine; Vindesine

1998
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA).
    Blood, 2000, Jun-15, Volume: 95, Issue:12

    Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Mitoxantrone; Multivariate Analysis; Prednisone; Quality of Life; Survival Analysis; Transplantation, Autologous; Vindesine

2000
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:16

    Topics: Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Statistics, Nonparametric; Vindesine

2000
Primary lymphoma of bone: a prospective study of 28 cases.
    Joint bone spine, 2000, Volume: 67, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Surveys and Questionnaires; Survival Rate; Treatment Outcome; Vindesine

2000
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
    The hematology journal : the official journal of the European Haematology Association, 2001, Volume: 2, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine

2001
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial.
    Onkologie, 1990, Volume: 13, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Vincristine; Vindesine

1990
[Aclarubicin-combined combination chemotherapy in patients with refractory or relapsed non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:1

    Topics: Aclarubicin; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multicenter Studies as Topic; Prednisolone; Recurrence; Remission Induction; T-Lymphocytes; Vinblastine; Vindesine

1989
[Phase III study of chemotherapy in low-malignancy non-Hodgkin's lymphomas: comparison of vincristine-vindesine combination chemotherapy].
    Onkologie, 1987, Volume: 10, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Vincristine; Vindesine

1987

Other Studies

36 other study(ies) available for vindesine and Diffuse Mixed Small and Large Cell Lymphoma

ArticleYear
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
    Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:6

    Topics: Cyclophosphamide; Doxorubicin; Drug Stability; Epirubicin; Etoposide; Humans; Infusion Pumps; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Vindesine

2019
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
    Journal of the National Cancer Institute, 2013, Aug-07, Volume: 105, Issue:15

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine

2013
[Clinical study of COAD-B regimen in treatment of patients with relapsed/refractory non-Hodgkin lymphoma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2013, Volume: 34, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Humans; Lymphoma, Non-Hodgkin; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome; Vindesine

2013
[Localized primary bone lymphoma: about four cases].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:1

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Clavicle; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Femoral Neoplasms; Fractures, Spontaneous; Humans; Humeral Fractures; Humerus; Lymphoma, Non-Hodgkin; Male; Mandibular Neoplasms; Middle Aged; Osteolysis; Prednisone; Prognosis; Radioisotope Teletherapy; Remission Induction; Rituximab; Vincristine; Vindesine

2014
Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies.
    Human antibodies, 2010, Volume: 19, Issue:1

    Topics: Adult; Aged; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carmustine; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vidarabine; Vincristine; Vindesine

2010
[Acute respiratory distress syndrome due to pneumonitis following intrathecal methotrexate administration].
    Revue des maladies respiratoires, 2003, Volume: 20, Issue:2 Pt 1

    Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cyclophosphamide; Doxorubicin; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Spinal; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pneumonia; Recombinant Proteins; Respiratory Distress Syndrome; Steroids; Tomography, X-Ray Computed; Vindesine

2003
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.
    Blood, 2004, Feb-15, Volume: 103, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Risk Factors; Vindesine

2004
Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    The New England journal of medicine, 2005, Mar-24, Volume: 352, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Prognosis; Vincristine; Vindesine

2005
Treatment of localized lymphoma.
    The New England journal of medicine, 2005, Jun-09, Volume: 352, Issue:23

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Vindesine

2005
Treatment of localized lymphoma.
    The New England journal of medicine, 2005, Jun-09, Volume: 352, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Survival Analysis; Vincristine; Vindesine

2005
Treatment of localized lymphoma.
    The New England journal of medicine, 2005, Jun-09, Volume: 352, Issue:23

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Vincristine; Vindesine

2005
Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
    Cancer treatment reports, 1983, Volume: 67, Issue:5

    Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vinblastine; Vindesine

1983
[Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
    Bulletin du cancer, 1981, Volume: 68, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Hodgkin Disease; Humans; Infusions, Parenteral; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Vinblastine; Vindesine

1981
Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM).
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1993, Volume: 47, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine; Vindesine

1993
[Initial anthracycline-based chemotherapy without radiotherapy in patients older than 70 years with localized lymphoma arising from Waldeyer's ring].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:15

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisolone; Remission Induction; Survival Rate; Tonsillar Neoplasms; Vindesine

1993
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Vindesine

1996
Decreased lymphocytic proliferation by mitogens in patients with transitional cell carcinoma of the renal pelvis subsequent to non-Hodgkin's lymphoma.
    American journal of hematology, 1996, Volume: 51, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Transitional Cell; Cocarcinogenesis; Cyclophosphamide; Doxorubicin; Humans; Immunologic Deficiency Syndromes; Kidney Neoplasms; Kidney Pelvis; Lymphocyte Activation; Lymphoma, Non-Hodgkin; Male; Mitogens; Neoplasms, Second Primary; Prednisolone; Smoking; T-Lymphocytes; Vincristine; Vindesine

1996
Clinical course and outcome of patients with Hodgkin's disease who progress after autologous transplantation.
    Leukemia & lymphoma, 1995, Volume: 20, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vindesine; Whole-Body Irradiation

1995
[Treatment of aggressive non Hodgkin's lymphoma: the experience of a general hospital].
    Bulletin du cancer, 1996, Volume: 83, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Hospitals, General; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Survival Analysis; Vincristine; Vindesine

1996
[Diagnosis and therapeutic management of gastric lymphomas].
    Sangre, 1996, Volume: 41, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gastrectomy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitomycin; Prednisone; Radioisotope Teletherapy; Remission Induction; Retrospective Studies; Spain; Stomach Neoplasms; Treatment Outcome; Vincristine; Vindesine

1996
Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
    Blood, 1998, May-15, Volume: 91, Issue:10

    Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; DNA, Neoplasm; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Genotype; Haplotypes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prednisone; Proportional Hazards Models; Survival Analysis; Transcription, Genetic; Treatment Outcome; Tumor Necrosis Factor-alpha; Vincristine; Vindesine

1998
Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma.
    Bone marrow transplantation, 1999, Volume: 24, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prognosis; Salvage Therapy; Transplantation Conditioning; Venous Thrombosis; Vindesine

1999
Non-Hodgkin's lymphoma followed by plasmacytoma, both arising in A thyroid gland with Hashimoto's disease.
    Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Cisplatin; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Gene Rearrangement, B-Lymphocyte; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasms, Second Primary; Neoplastic Stem Cells; Plasmacytoma; Radiotherapy, Adjuvant; Remission Induction; Thyroid Neoplasms; Thyroidectomy; Thyroiditis, Autoimmune; Vindesine

1999
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2000, Volume: 39, Issue:1-2

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Treatment Outcome; Vindesine

2000
[Prognostic factors, late relapse and outcome of patients with aggressive malignant lymphoma: long term results of LNH-80 protocol].
    Bulletin du cancer, 1992, Volume: 79, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Treatment Outcome; Vindesine

1992
Non-Hodgkin's lymphoma associated with human immunodeficiency virus: treatment with LNH 84 regimen in a selected group of patients.
    Leukemia, 1992, Volume: 6 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Pilot Projects; Prednisolone; Prognosis; Remission Induction; Vindesine

1992
Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
    Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Salvage Therapy; Vindesine

1992
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:14

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Rate; Vindesine

1992
[Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Recurrence; Vincristine; Vindesine

1992
Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisolone; Prognosis; Remission Induction; Survival Rate; Vindesine

1991
[Epirubicin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma: with emphasis of elderly patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Humans; Injections, Intravenous; Lymphoma, Non-Hodgkin; Male; Prednisolone; Remission Induction; Survival Rate; Vindesine

1990
VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Remission Induction; Vindesine

1989
[Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas].
    Sangre, 1989, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug Resistance; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Vindesine

1989
Methylprednisolone, etoposide, vindesine, and chlorambucil (PEEC) alone or alternating with CHOP as initial or salvage therapy for non-Hodgkin's lymphoma.
    Scottish medical journal, 1988, Volume: 33, Issue:6

    Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Nausea; Prednisone; Prognosis; Remission Induction; Vincristine; Vindesine

1988
Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, vindesine, methotrexate with leucovorin rescue. Greek Lymphoma Research Group.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Vindesine

1987
Methotrexate-vindesine association in leukemia: pharmacokinetic study.
    Medical oncology and tumor pharmacotherapy, 1985, Volume: 2, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Humans; Infusions, Parenteral; Kinetics; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Vindesine

1985